Objectives To compare the diagnostic accuracy of MRI and PET/CT combined versus standard staging methods (CT, endoscopic ultrasound [EUS], and PET/CT) for initial staging of esophageal cancer (EC). Materials and methods This study included patients newly diagnosed with histologically proven EC between 2017 and 2021. Patients underwent a 3-T esophageal MRI alongside standard staging (CT, EUS, PET/CT) prior to treatment. TNM-stages were assessed by two independent reviewers for MRI, CT, and PET/CT, with EUS evaluated by one operator. Discrepancies were resolved by a third reviewer. Patients were categorized based on treatment management: surgery (T1-T2N0M0), neoadjuvant (radio)chemotherapy (T3-T4a and/or N1-N2-N3M0), and palliative chemotherapy (T4b and/or M1). The reference standard was histopathology from surgical specimens or TNM staging from tumor board discussions. The area under the curve (AUC) was calculated for each imaging combination. Results 60 patients newly diagnosed with EC (50M/10F; mean age 66.5 years) were prospectively enrolled. MRI + PET/CT combination exhibited the highest AUC (0.92, 95% CI: 0.79–1) for differentiating curative versus palliative patients, without statistically significant difference compared to CT + EUS (0.80, 95% CI: 0.56–1, p = 0.34), CT + PET/CT (0.77, 95% CI: 0.53–1, p = 0.42), and CT + EUS + PET/CT (0.78, 95% CI: 0.58–0.97, p = 0.26). In term of differentiating patients eligible for upfront surgery from those with indication for neoadjuvant (radio)chemotherapy, the combination of CT + EUS + PET/CT demonstrated the highest AUC (0.90, 95% CI: 0.75–1) without statistically significant difference compared to CT + EUS (0.82, 95% CI: 0.56–1, p = 0.49), CT + PET/CT (0.79, 95% CI: 0.46–1, p = 0.36), and MRI + PET/CT (0.83, 95% CI: 0.65–1, p = 0.59). Conclusion MRI + PET/CT combination is highly accurate for initial EC staging and non-inferior to standard methods, offering less invasiveness and reduced radiation exposure. Key Points <Emphasis Type="BoldItalic">Question</Emphasis> Can MRI help improve the TNM staging of esophageal cancer? <Emphasis Type="BoldItalic">Findings</Emphasis> MRI + PET/CT showed no statistically significant difference compared to endoscopic ultrasound (EUS) + CT + PET/CT in identifying curative vs palliative patients but with a tendency for improved staging. <Emphasis Type="BoldItalic">Clinical relevance</Emphasis> Thoraco-abdominal MRI can provide added value (as a replacement of CT and EUS) in initial staging of esophagus cancer, particularly in cases of stenotic or advanced tumors. Graphical Abstract

Evaluation of MRI for initial staging of esophageal cancer: the STIRMCO study

期刊论文
出版模式：

开放获取
发表日期：

2025年5月16日

查看全文

Vincent Levy,
Mario Jreige,
Laura Haefliger,
Celine Du Pasquier,
Camille Noirot,
Anna Dorothea Wagner,
Styliani Mantziari,
Markus Schäfer,
Naik Vietti-Violi,
Clarisse Dromain

摘要

Objectives

To compare the diagnostic accuracy of MRI and PET/CT combined versus standard staging methods (CT, endoscopic ultrasound [EUS], and PET/CT) for initial staging of esophageal cancer (EC).

Materials and methods

This study included patients newly diagnosed with histologically proven EC between 2017 and 2021. Patients underwent a 3-T esophageal MRI alongside standard staging (CT, EUS, PET/CT) prior to treatment. TNM-stages were assessed by two independent reviewers for MRI, CT, and PET/CT, with EUS evaluated by one operator. Discrepancies were resolved by a third reviewer. Patients were categorized based on treatment management: surgery (T1-T2N0M0), neoadjuvant (radio)chemotherapy (T3-T4a and/or N1-N2-N3M0), and palliative chemotherapy (T4b and/or M1). The reference standard was histopathology from surgical specimens or TNM staging from tumor board discussions. The area under the curve (AUC) was calculated for each imaging combination.

Results

60 patients newly diagnosed with EC (50M/10F; mean age 66.5 years) were prospectively enrolled. MRI + PET/CT combination exhibited the highest AUC (0.92, 95% CI: 0.79–1) for differentiating curative versus palliative patients, without statistically significant difference compared to CT + EUS (0.80, 95% CI: 0.56–1, p = 0.34), CT + PET/CT (0.77, 95% CI: 0.53–1, p = 0.42), and CT + EUS + PET/CT (0.78, 95% CI: 0.58–0.97, p = 0.26). In term of differentiating patients eligible for upfront surgery from those with indication for neoadjuvant (radio)chemotherapy, the combination of CT + EUS + PET/CT demonstrated the highest AUC (0.90, 95% CI: 0.75–1) without statistically significant difference compared to CT + EUS (0.82, 95% CI: 0.56–1, p = 0.49), CT + PET/CT (0.79, 95% CI: 0.46–1, p = 0.36), and MRI + PET/CT (0.83, 95% CI: 0.65–1, p = 0.59).

Conclusion

MRI + PET/CT combination is highly accurate for initial EC staging and non-inferior to standard methods, offering less invasiveness and reduced radiation exposure.

Key Points

Question Can MRI help improve the TNM staging of esophageal cancer?

Findings MRI + PET/CT showed no statistically significant difference compared to endoscopic ultrasound (EUS) + CT + PET/CT in identifying curative vs palliative patients but with a tendency for improved staging.

Clinical relevance Thoraco-abdominal MRI can provide added value (as a replacement of CT and EUS) in initial staging of esophagus cancer, particularly in cases of stenotic or advanced tumors.

Graphical Abstract